Bluejay Diagnostics (BJDX) Cash & Current Investments (2022 - 2023)
Bluejay Diagnostics' Cash & Current Investments history spans 2 years, with the latest figure at $5.1 million for Q3 2023.
- For Q3 2023, Cash & Current Investments fell 61.8% year-over-year to $5.1 million; the TTM value through Sep 2023 reached $5.1 million, down 61.8%, while the annual FY2022 figure was $10.1 million, N/A changed from the prior year.
- Cash & Current Investments for Q3 2023 was $5.1 million at Bluejay Diagnostics, roughly flat from $5.1 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $17.1 million in Q1 2022 and bottomed at $5.1 million in Q3 2023.